Serum ammonia predicts mortality in patients with hepatocellular carcinoma

被引：0
|
作者：
Guerra, P. [1 ]
Cagnin, S. [1 ]
Caspanello, A. R. [2 ]
Libralesso, E. [1 ]
Tonon, M. [1 ]
Gambino, C. [1 ]
Piano, S. [1 ]
Pontisso, P. [1 ]
Martini, A. [1 ]
Angeli, P. [1 ]
机构：
[1] Univ Padua, Dept Med, Unit Hepatol & Interna Med, Padua, Italy
[2] Univ Messina, Dept Clin & Expt Med, Unit Med & Hepatol, Messina, Italy
来源：
DIGESTIVE AND LIVER DISEASE | 2024年 / 56卷
关键词：
D O I：
10.1016/j.dld.2024.01.160
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
F-55
引用
收藏
页码：S91 / S92
页数：2
相关论文
共 50 条
  • [1] Dynopenia predicts mortality in patients with liver cirrhosis and hepatocellular carcinoma
    Gallo, P.
    Flagiello, V.
    De Vincentis, A.
    Di Cola, S.
    Terracciani, F.
    Falcomata, A.
    Picardi, A.
    Vespasiani-Gentilucci, U.
    DIGESTIVE AND LIVER DISEASE, 2025, 57 : S45 - S46
  • [2] Serum Irisin Predicts Posthepatectomy Complications in Patients with Hepatocellular Carcinoma
    Zhang, Jia
    Ke, Mengyun
    Ren, Yifan
    Bi, Jianbin
    Du, Zhaoqing
    Zhang, Mei
    Wang, Yawen
    Zhang, Lin
    Wu, Zheng
    Lv, Yi
    Wu, Rongqian
    DISEASE MARKERS, 2019, 2019
  • [3] Serum soluble DR5 predicts mortality risk in patients with HBV-related hepatocellular carcinoma
    Liang, Jiaqi
    Feng, Ying
    Liu, Yao
    Shi, Ke
    Zhou, Guiqin
    Liu, Long
    Liu, Yaxin
    Qiao, Kexin
    Liu, Wen
    Wang, Xianbo
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [4] Serum Ammonia at Admission Predicts In-Hospital Mortality in Patients With Alcoholic Hepatitis
    Ravi, Sujan
    Bade, Kaely
    Singal, Ashwani
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 : S155 - S155
  • [5] Serum Ammonia Predicts Mortality in Hospitalized Patients With End-Stage Liver Disease
    Patwardhan, Vilas R.
    Jiang, Z. Gordon
    Piatkowski, Gail
    Afdhal, Nezam H.
    Mukamal, Kenneth
    Curry, Michael P.
    Tapper, Elliot B.
    GASTROENTEROLOGY, 2014, 146 (05) : S989 - S990
  • [6] Serum GP73 predicts posthepatectomy outcomes in patients with hepatocellular carcinoma
    Ke, Meng-yun
    Wu, Xiao-ning
    Zhang, Yao
    Wang, Saisai
    Lv, Yi
    Dong, Jian
    JOURNAL OF TRANSLATIONAL MEDICINE, 2019, 17 (1)
  • [7] Serum osteopontin predicts the response to atezolizumab plus bevacizumab in patients with hepatocellular carcinoma
    Reika Yamauchi
    Takanori Ito
    Sachiyo Yoshio
    Takafumi Yamamoto
    Kazuyuki Mizuno
    Masatoshi Ishigami
    Hiroki Kawashima
    Satoshi Yasuda
    Shigeo Shimose
    Hideki Iwamoto
    Taiji Yamazoe
    Taizo Mori
    Eiji Kakazu
    Takumi Kawaguchi
    Hidenori Toyoda
    Tatsuya Kanto
    Journal of Gastroenterology, 2023, 58 : 565 - 574
  • [8] Serum GP73 predicts posthepatectomy outcomes in patients with hepatocellular carcinoma
    Meng-yun Ke
    Xiao-ning Wu
    Yao Zhang
    Saisai Wang
    Yi Lv
    Jian Dong
    Journal of Translational Medicine, 17
  • [9] Serum osteopontin predicts the response to atezolizumab plus bevacizumab in patients with hepatocellular carcinoma
    Yamauchi, Reika
    Ito, Takanori
    Yoshio, Sachiyo
    Yamamoto, Takafumi
    Mizuno, Kazuyuki
    Ishigami, Masatoshi
    Kawashima, Hiroki
    Yasuda, Satoshi
    Shimose, Shigeo
    Iwamoto, Hideki
    Yamazoe, Taiji
    Mori, Taizo
    Kakazu, Eiji
    Kawaguchi, Takumi
    Toyoda, Hidenori
    Kanto, Tatsuya
    JOURNAL OF GASTROENTEROLOGY, 2023, 58 (06) : 565 - 574
  • [10] Serum endostatin predicts tumor vascularity in hepatocellular carcinoma
    Tez, M
    Tez, S
    CANCER, 2003, 98 (05) : 1101 - 1101
12345